<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01439776</url>
  </required_header>
  <id_info>
    <org_study_id>ML25569</org_study_id>
    <nct_id>NCT01439776</nct_id>
  </id_info>
  <brief_title>Add Vitamin D With Standard of Care for Chronic Hepatitis C Patients</brief_title>
  <acronym>Addwin</acronym>
  <official_title>A Randomized, Multi-center, Phase IV Open-label Study Evaluating the Antiviral Efficacy of Addition of Vitamin D in Patients With Treatment Naïve Chronic Hepatitis C Receiving Peginterferon Alfa-2a Plus Ribavirin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hanyang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Roche Pharma AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hanyang University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Standard therapy for chronic hepatitis C virus (HCV) is (Peg/RBV) combination therapy
      obtaining sustained virologic response (SVR) in 77% of naïve patients with genotype 1-3
      Studies rarely address the issues of improving host factors. The current study examines
      whether adding vitamin D with Peg/RBV, a potent immunomodulator, could improve viral
      response(SVR)compared to Peg/RBV.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The working hypothesis is that Adding vitamin D to conventional Peg/RBV therapy for naïve,
      genotype 1-3 patients with chronic HCV infection significantly improves RVR, EVR
      additionally.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">August 2013</completion_date>
  <primary_completion_date type="Anticipated">February 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with Sustained virologic response (SVR)</measure>
    <time_frame>24w after completing Peg/RBV</time_frame>
    <description>Compare the number of participants with HCV RNA is not detected in the blood at 24 weeks post-treatment between vitamin D and control group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with End of treatment response (ETR)</measure>
    <time_frame>48 weeks at Genotype 1, 24 weeks at Genotye 2 and 3</time_frame>
    <description>Compare the number of participants with HCV RNA is not detected in the blood at the end of treatment between two groups.
HCV RNA pCR perform at 48 weeks in genotye 1, at 24 weeks in Genotye 2 and 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with Rapid virological response (RVR)</measure>
    <time_frame>Week 4</time_frame>
    <description>Compare the number of participants with HCV RNA is notdetectable in the blood at week 4 of treatment between vitamin and control group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with Early virological response (EVR)</measure>
    <time_frame>Week 12</time_frame>
    <description>Compare the number of participants with HCV RNA cannot be detected in the blood at week 12 of treatment between viatmin and control group</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">222</enrollment>
  <condition>Chronic Hepatitis C</condition>
  <arm_group>
    <arm_group_label>Peginterferon alfa 2a+Ribavirin</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard of care for HCV : peginterferon alfa 2a and ribavirin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vit D+Peginterferon alfa 2a+Ribavirin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>VitD+Peginterferon alfa 2a+Ribavirin</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vit D</intervention_name>
    <description>800IU/day</description>
    <arm_group_label>Vit D+Peginterferon alfa 2a+Ribavirin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic genotype 1-3 HCV infection

          -  Treatment Naive

        Exclusion Criteria:

          -  Child B and C

          -  HCC patients

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Daewon Jun, professor</last_name>
    <phone>82222909501</phone>
    <email>noshin@hanyang.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jungmin Cho, CRC</last_name>
    <phone>82222909501</phone>
    <email>01sin03@naver.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Soonchunhyang university Hospital Cheonan</name>
      <address>
        <city>Cheonan</city>
        <state>Chungcheongnam-do</state>
        <zip>330721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Saehwan Lee, Professor</last_name>
      <email>stevesh@schmc.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Saehwan Lee, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Soonchunhyang university hospital Bucheon</name>
      <address>
        <city>Bucheon</city>
        <state>Gyeonggi-do</state>
        <zip>420767</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sanggyune Kim, professor</last_name>
      <email>mcnulty@schbc.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Sanggyune Kim, professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HANYANG University Guri Hospital</name>
      <address>
        <city>Guri</city>
        <state>Gyeonggido</state>
        <zip>471701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joohyun Sohn, Professor</last_name>
      <email>sonjh@hanyang.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Joohyun Sohn, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bundang Jesaeng Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggido</state>
        <zip>463774</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bohyun Kim, M.D.</last_name>
      <email>bohkim@medimail.co.kr</email>
    </contact>
    <investigator>
      <last_name>Bohyun Kim, Kwajang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chuncheon Sacred Heart Hospital</name>
      <address>
        <city>Chuncheon</city>
        <state>Kangwondo</state>
        <zip>200704</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kitae Suk, Professor</last_name>
      <email>ktsuk@hallym.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Kitae Suk, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wonju Christian Hospital</name>
      <address>
        <city>Wonju</city>
        <state>Kangwondo</state>
        <zip>220-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Munyeong Kim, Professor</last_name>
    </contact>
    <investigator>
      <last_name>Munyeong Kim, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kyong Hee University Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>130702</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>JaeJoon Shim, Professor</last_name>
      <email>joyshim@khu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>JaeJoon Shim, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hanyang University Seoul Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>133792</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daewon Jun, Professor</last_name>
      <email>noshin@hanyang.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Daewon Jun, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kangdong Sacred Heart Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>134701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hyungsu Kim, Professor</last_name>
      <email>hskim@hallym.or.kr</email>
    </contact>
    <investigator>
      <last_name>Hyungsoo Kim, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gangnam Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>135720</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jakyung Kim, Professor</last_name>
      <email>ceciliak@yuhs.ac</email>
    </contact>
    <investigator>
      <last_name>Jakyung Kim, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sooncunhayng University Hospital Seoul</name>
      <address>
        <city>Seoul</city>
        <zip>140887</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Soungwon Jeong, professor</last_name>
      <email>jeongsw@hosp.sch.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Soungwon Jeong, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>BORAMAE Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>156707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Won Kim, professor</last_name>
      <email>drwon1@snu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Won Kim, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chungang University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>156861</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hyunwoong Lee, Professor</last_name>
      <email>lhwdoc@hanmail.net</email>
    </contact>
    <investigator>
      <last_name>Hyunwoong Lee, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2011</study_first_submitted>
  <study_first_submitted_qc>September 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2011</study_first_posted>
  <last_update_submitted>September 22, 2011</last_update_submitted>
  <last_update_submitted_qc>September 22, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hanyang University</investigator_affiliation>
    <investigator_full_name>Dae Won Jun</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>chronic hepatitis C</keyword>
  <keyword>SVR</keyword>
  <keyword>Vit D</keyword>
  <keyword>Peginterferon alfa 2a</keyword>
  <keyword>Ribavirin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Hepatitis, Chronic</mesh_term>
    <mesh_term>Hepatitis C, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ribavirin</mesh_term>
    <mesh_term>Peginterferon alfa-2a</mesh_term>
    <mesh_term>Interferon-alpha</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

